Palisade Bio (PALI) Receivables - Other (2016 - 2023)
Palisade Bio (PALI) reported Receivables - Other of $105625.0 for Q4 2023, down 25.22% year-over-year from $141250.0 in Q4 2022, and little changed quarter-over-quarter from $105625.0 in Q3 2023.
Palisade Bio (PALI) Receivables - Other (2016 - 2023) Analysis & Trends
Palisade Bio (PALI) has 7 years of Receivables - Other data on file, last reported at $105625.0 in Q4 2023.
- Receivables - Other for Q4 2023 came in at $105625.0, down 25.22% year-over-year; the trailing twelve-month figure through Dec 2023 was $105625.0 (down 25.22% YoY), and the FY2023 annual result was $105625.0, down 25.22% from the prior year.
- Receivables - Other held at $105625.0 in Q4 2023 per PALI's latest filing, from $105625.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $229000.0 in Q1 2019 and troughed at $105625.0 in Q2 2023.
- A 4-year average of $187375.0 and a median of $229000.0 in 2019 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2019 and 2023: Receivables - Other jumped 267.88% in 2019, then slipped 25.22% in 2023.
- A 4-year view of Receivables - Other shows it stood at $229000.0 in 2019, then changed by 0.0% to $229000.0 in 2020, then sank by 38.32% to $141250.0 in 2022, then decreased by 25.22% to $105625.0 in 2023.
- Business Quant data shows PALI's Receivables - Other at $105625.0 in Q4 2023, $105625.0 in Q3 2023, and $105625.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 105,625.00 |
| Dec 31, 2023 | 105,625.00 |
| Sep 30, 2023 | 105,625.00 |
| Sep 30, 2023 | 105,625.00 |
| Jun 30, 2023 | 105,625.00 |
| Jun 30, 2023 | 105,625.00 |
| Dec 31, 2022 | 141,250.00 |
| Dec 31, 2022 | 141,250.00 |
| Dec 31, 2020 | 229,000.00 |
| Dec 31, 2020 | 229,000.00 |
| Sep 30, 2020 | 229,000.00 |
| Sep 30, 2020 | 229,000.00 |
| Jun 30, 2020 | 229,000.00 |
| Jun 30, 2020 | 229,000.00 |
| Mar 31, 2020 | 229,000.00 |
| Mar 31, 2020 | 229,000.00 |
| Sep 30, 2019 | 229,000.00 |
| Sep 30, 2019 | 229,000.00 |
| Jun 30, 2019 | 229,000.00 |
| Jun 30, 2019 | 229,000.00 |